Schmidt K G
Abteilung für Pädiatrische Kardiologie, Universitäts-Kinderklinik Heidelberg.
Schweiz Med Wochenschr. 1998 Sep 26;128(39):1436-43.
Over the past 15 years considerable advances in ultrasonography have made increasingly detailed evaluation of the human foetal heart feasible. Accordingly, the presence of cardiac failure can now be diagnosed in human foetuses during the last two thirds of pregnancy by foetal echocardiography. The underlying causes of foetal cardiac failure can be identified and prenatal treatment, if considered appropriate, can be monitored by ultrasonographic methods. Two-dimensional and M-mode echocardiography, as well as Doppler ultrasound, are equally important with respect to evaluation of foetal cardiac failure. Foetal echocardiography has contributed remarkably to broadening our understanding of the conditions and natural course of cardiac failure during prenatal life. In turn, this has led to an increasing readiness to consider new forms of prenatal treatment for foetal cardiac failure.
在过去15年里,超声检查技术取得了长足进步,使得对人类胎儿心脏进行越来越详细的评估成为可能。因此,现在可以通过胎儿超声心动图在妊娠最后三分之二阶段诊断出人类胎儿是否存在心力衰竭。胎儿心力衰竭的潜在病因能够被识别出来,并且如果认为合适的话,产前治疗可以通过超声检查方法进行监测。二维和M型超声心动图以及多普勒超声在评估胎儿心力衰竭方面同样重要。胎儿超声心动图极大地有助于拓宽我们对产前心力衰竭状况和自然病程的认识。反过来,这也使得人们越来越愿意考虑针对胎儿心力衰竭的新的产前治疗形式。